MILAD RIAZIFAR

Co-Founder and CEO

Co-founder

Entelexo Biotherapeutics· Winter 2021🇺🇸 Irvine, California, United States

in LinkedIn

2021Co-founder· Entelexo Biotherapeutics

Founder · since 2021

Company

Entelexo Biotherapeutics

Role

Cofounder and CEO

current

Stage

—

no public source

Raised

—

no public source

Based

—

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

Entelexo Biotherapeutics

Creating a New Class of Drugs to Address Incurable Autoimmune Diseases

Winter 2021

Experience

Career

Entelexo Biotherapeutics
Co-founder
Cofounder and CEO · 2021 – Present
2021
City of Hope
Scientist - Department of Cellular Therapeutics · Duarte, CA · 2017 – 2019
2017
UC Irvine
Ph.D. Candidate · Sue and Bill Gross Stem Cell Research Center · 2013 – 2017
2013
UC Irvine
Research Associate · Irvine · 2011 – 2013
2011
Amgen
Intern - Therapeutic Discovery · Thousand Oaks, CA · 2016
2016

Bio

Dr. Riazifar has worked on stem cells over a decade and on exosomes a subclass of stem cell derived extracellular vesicles since 2012. During his Ph.D studies at the Stem Cell Research Center at the University of California Irvine, he pioneered a cell-free exosome-based approach to treat Multiple Sclerosis. At City of Hope, he was part of a clinical translation team initiating the world’s first clinical trial using stem cell exosomes for the treatment of type I diabetes.